Catalyst Wire Dossier Catalyst Wire Dossier

Aramchol Meglumine

· Galmed Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aramchol Meglumine, covering 2025-06-12 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis [Phase 2]

See pricing